These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18615702)

  • 1. Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging.
    Scholtzova H; Wadghiri YZ; Douadi M; Sigurdsson EM; Li YS; Quartermain D; Banerjee P; Wisniewski T
    J Neurosci Res; 2008 Sep; 86(12):2784-91. PubMed ID: 18615702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. False recognition in a mouse model of Alzheimer's disease: rescue with sensory restriction and memantine.
    Romberg C; McTighe SM; Heath CJ; Whitcomb DJ; Cho K; Bussey TJ; Saksida LM
    Brain; 2012 Jul; 135(Pt 7):2103-14. PubMed ID: 22466291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
    Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease.
    Jürgenson M; Zharkovskaja T; Noortoots A; Morozova M; Beniashvili A; Zapolski M; Zharkovsky A
    J Pharm Pharmacol; 2019 Nov; 71(11):1695-1705. PubMed ID: 31531878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome.
    Rueda N; Llorens-Martín M; Flórez J; Valdizán E; Banerjee P; Trejo JL; Martínez-Cué C
    J Alzheimers Dis; 2010; 21(1):277-90. PubMed ID: 20421694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice.
    Liu MY; Wang S; Yao WF; Zhang ZJ; Zhong X; Sha L; He M; Zheng ZH; Wei MJ
    Neuroscience; 2014 Jul; 273():141-51. PubMed ID: 24846616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memantine ameliorates cognitive deficit in AD mice via enhancement of entorhinal-CA1 projection.
    Li P; Xu J; Gu H; Peng H; Yin Y; Zhuang J
    BMC Neurosci; 2021 Jun; 22(1):41. PubMed ID: 34120588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic Acid potentiates the effect of memantine on spatial learning and neuronal protection in an Alzheimer's disease transgenic model.
    Chen TF; Huang RF; Lin SE; Lu JF; Tang MC; Chiu MJ
    J Alzheimers Dis; 2010; 20(2):607-15. PubMed ID: 20164552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (A beta) peptide in the human neuroblastoma cells.
    Ray B; Banerjee PK; Greig NH; Lahiri DK
    Neurosci Lett; 2010 Feb; 470(1):1-5. PubMed ID: 19948208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.
    Ettcheto M; Sánchez-López E; Gómez-Mínguez Y; Cabrera H; Busquets O; Beas-Zarate C; García ML; Carro E; Casadesus G; Auladell C; Vázquez Carrera M; Folch J; Camins A
    Mol Neurobiol; 2018 Sep; 55(9):7327-7339. PubMed ID: 29404958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Memantine Treatment and Combination with Vitamin D Supplementation on Body Composition in the APP/PS1 Mouse Model of Alzheimer's Disease Following Chronic Vitamin D Deficiency.
    Wong D; Broberg DN; Doad J; Umoh JU; Bellyou M; Norley CJD; Holdsworth DW; Montero-Odasso M; Beauchet O; Annweiler C; Bartha R
    J Alzheimers Dis; 2021; 81(1):375-388. PubMed ID: 33780366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
    Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y
    BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP/PS1 mouse model of Alzheimer's disease.
    Filali M; Lalonde R; Rivest S
    Neuropharmacology; 2011 May; 60(6):930-6. PubMed ID: 21281652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
    Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
    Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Memantine Treatment Ameliorates Behavioral Deficits, Neuron Loss, and Impaired Neurogenesis in a Model of Alzheimer's Disease.
    Stazi M; Wirths O
    Mol Neurobiol; 2021 Jan; 58(1):204-216. PubMed ID: 32914393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy.
    Deng M; Huang L; Ning B; Wang N; Zhang Q; Zhu C; Fang Y
    Brain Res; 2016 Dec; 1652():188-194. PubMed ID: 27737765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice.
    Zhang J; Guo J; Zhao X; Chen Z; Wang G; Liu A; Wang Q; Zhou W; Xu Y; Wang C
    Behav Brain Res; 2013 Aug; 250():230-7. PubMed ID: 23685322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
    Wu M; Shi H; He Y; Yuan L; Qu X; Zhang J; Wang Z; Cai H; Qi J
    J Alzheimers Dis; 2017; 59(3):1067-1078. PubMed ID: 28731445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice.
    Mori T; Koyama N; Tan J; Segawa T; Maeda M; Town T
    J Biol Chem; 2019 Feb; 294(8):2714-2731. PubMed ID: 30563837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.